Sasha J Mayer

Title: Innovations by Sasha J Mayer in Nucleic Acid Delivery

Introduction

Sasha J Mayer is an accomplished inventor based in Snohomish, WA (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid delivery systems. His innovative work focuses on enhancing the delivery of nucleic acids into cells, which has important implications for gene therapy and genetic research.

Latest Patents

Mayer holds a patent for "Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells." This patent describes polynucleotide delivery-enhancing polypeptides that are either admixed, complexed, or conjugated with nucleic acids to improve their delivery into target cells. The nucleic acids transported are active as small inhibitory nucleic acids (siNAs) that modulate the expression of target genes, primarily through RNA interference (RNAi). The compositions and methods outlined in this patent provide effective tools for modulating gene expression and altering phenotypes in mammalian cells, potentially eliminating disease symptoms or altering disease potential in targeted cells.

Career Highlights

Mayer is currently associated with Marina Biotech, Inc., where he continues to advance his research in nucleic acid delivery systems. His work is pivotal in developing new therapeutic strategies that leverage RNAi technology for medical applications.

Collaborations

Mayer collaborates with notable colleagues in his field, including Lishan Chen and Kunyuan Cui. These partnerships enhance the research and development efforts at Marina Biotech, Inc., fostering innovation in nucleic acid delivery technologies.

Conclusion

Sasha J Mayer's contributions to the field of nucleic acid delivery represent a significant advancement in genetic research and therapy. His innovative approaches have the potential to transform how diseases are treated at the molecular level.